Metabolon Closes $15 Million Series E Financing|
Monday, January 06, 2014
Company raises $15 million through the issuance of preferred stock.
Innovative Screening Strategy Swiftly Uncovers New Drug Candidates, New Biology
Tuesday, December 24, 2013
Method has been utilised to identify compound with promise for obesity-linked diabetes.
AstraZeneca to Acquire Bristol-Myers Squibb Share of Global Diabetes Alliance Assets
Monday, December 23, 2013
Global agreement strengthens AstraZeneca’s commitment to diabetes.
Research Point to Enzyme that Restores Function in Diabetic Kidney Disease
Saturday, December 14, 2013
Data on recent kidney metabolomics findings discussed at the American Society of Nephrology Kidney Week Meeting.
ClinMet Metabolomics Platform Offers Unique Insights into Diabetic Kidney Disease
Friday, December 13, 2013
Findings overturn previous belief regarding relationship of mitochondrial activity and diabetic complications.
Metabolomics as a Diagnostic Tool in Gastroenterology
Thursday, December 12, 2013
This review summarizes contributions that metabolomics has made in IBD and IBS and presents potential future directions within the field.
Agilent Thought Leader Award Supports Dr. Junying Yuan, Chinese Academy of Sciences
Wednesday, December 11, 2013
Integrated biological research is accelerating drug development for neurodegenerative diseases.
New England Venture Summit to Showcase Matrix-Bio
Monday, December 09, 2013
Matrix-Bio is seeking investment for its colon cancer-monitoring test.
New Statistical Tools Being Developed for Mining Cancer Data
Monday, December 02, 2013
Team from Rice, BCM, UT Austin tackling big data variety.